A PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTORMODIFIED T CELLS DIRECTED AGAINST CD19 IN PATIENTS WITH RELAPSED OR REFRACTORYCD19(+) B CELL LYMPHOMAS: INTERIM ANALYSIS
Ying, Z., Xiang, X., Song, Y., Ding, N., Lin, Y., Zheng, W., Wang, X., Lin, N., Tu, M., Xie, Y., Zhang, C., Liu, W., Deng, L., Liu, Y., Yue, Y., Yu, X., Liu, H., Duan, P., Chen, F., Wu, X., Huang, X.FVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2438_131
Date:
June, 2017
File:
PDF, 71 KB
english, 2017